These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32889673)

  • 1. The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer.
    Fujihata S; Ogawa R; Nakaya S; Hayakawa S; Okubo T; Sagawa H; Tanaka T; Takahashi H; Matsuo Y; Takiguchi S
    Esophagus; 2021 Apr; 18(2):258-266. PubMed ID: 32889673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
    Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
    Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
    Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
    Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy.
    Ishida T; Makino T; Yamasaki M; Yamashita K; Tanaka K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Eguchi H; Doki Y
    Ann Surg Oncol; 2021 Nov; 28(12):7185-7195. PubMed ID: 33876359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis.
    Wang P; Wang S; Li X; Lin G; Ma Y; Xiao R; Li H; Qiu M; Yang F
    Int J Surg; 2022 Jan; 97():106206. PubMed ID: 34990833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer.
    Harada T; Tsuji T; Ueno J; Koishihara Y; Konishi N; Hijikata N; Ishikawa A; Kotani D; Kojima T; Fujiwara H; Fujita T
    Ann Surg Oncol; 2022 Dec; 29(13):8131-8139. PubMed ID: 35978207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
    Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
    Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
    Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
    Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
    Wang YJ; Xie XF; He YQ; Bao T; He XD; Li KK; Guo W
    BMC Cancer; 2023 Dec; 23(1):1212. PubMed ID: 38066484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer.
    Kita R; Miyata H; Sugimura K; Tanaka K; Makino T; Yamashita K; Yamasaki M; Motoori M; Shiraishi O; Kimura Y; Yasuda T; Yano M; Doki Y
    Clin Nutr; 2021 Jun; 40(6):4380-4385. PubMed ID: 33526287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections.
    van Kooten RT; Ravensbergen CJ; van Büseck SCD; Grootjans W; Peeters KCMJ; Holman FA; Heemskerk JWT; Wouters MWJM; Navas Cañete A; Tollenaar RAEM
    J Surg Oncol; 2023 Apr; 127(5):823-830. PubMed ID: 36620908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
    Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
    World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal Muscle Loss During Neoadjuvant Chemotherapy Predicts the Incidence of Postoperative Infectious Complications in Esophageal Cancer Patients Undergoing Esophagectomy.
    Higashizono K; Sato S; Nakatani E; Hawke P; Nagai E; Taki Y; Nishida M; Watanabe M; Oba N
    Cancer Diagn Progn; 2023; 3(1):67-74. PubMed ID: 36632592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of end-to-side hand-sewn and side-to-side stapled cervical esophagogastric anastomosis in patients with lower thoracic esophageal cancer undergoing transhiatal esophagectomy: an Iranian retrospective cohort study.
    Rasihashemi SZ; Ramouz A; Beheshtirouy S; Amini H
    BMC Gastroenterol; 2020 Jul; 20(1):250. PubMed ID: 32736599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors of Cervical Anastomotic Leakage after McKeown Minimally Invasive Esophagectomy: Focus on Preoperative and Intraoperative Lung Function.
    Gao W; Wang M; Su P; Zhang F; Huang C; Tian Z
    Ann Thorac Cardiovasc Surg; 2021 Apr; 27(2):75-83. PubMed ID: 33087661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and risk factors of anastomotic leakage after radical esophagectomy].
    Chen C; Yu Z; Jin Q; Zhang X
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):518-21. PubMed ID: 26359075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer.
    Mayanagi S; Tsubosa Y; Omae K; Niihara M; Uchida T; Tsushima T; Yokota T; Sato H; Naito T; Yasui H
    Ann Surg Oncol; 2017 Nov; 24(12):3741-3747. PubMed ID: 28861809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.
    Shichinohe T; Uemura S; Hirano S; Hosokawa M
    Ann Surg Oncol; 2019 May; 26(5):1301-1310. PubMed ID: 30725311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation to the Gastric Fundus Increases the Risk of Anastomotic Leakage After Esophagectomy.
    Goense L; van Rossum PSN; Ruurda JP; van Vulpen M; Mook S; Meijer GJ; van Hillegersberg R
    Ann Thorac Surg; 2016 Dec; 102(6):1798-1804. PubMed ID: 27765168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.